Samsung Betting Billions on Biosimilars

The Samsung Group, one of the world's largest conglomerates, has announced its intention to invest billions of dollars to become a major player in the expanding biosimilars market. Read the Bloomberg report here.

 

More News:

All news »

What are your comments?

You cannot post comments until you have logged in. Login Here.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments